Skip to content

The Efficacy of Standardized Extract of Centella asiatica ECa 233 on the Healing effect after Erbium-YAG 2,940 nm laser: A Double-Blinded randomized control trial

The Efficacy of Standardized Extract of Centella asiatica ECa 233 on the Healing effect after Erbium-YAG 2,940 nm laser: A Double-Blinded randomized control trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20180927001
Enrollment
30
Registered
2018-09-27
Start date
2018-09-25
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne scars

Interventions

Apply Standard Extract of Centella asiatica ECa 233 and placebo on each side of the cheek after Erbium&#45
YAG laser 4 times/day for 7 days then twice daily for 12 weeks,Apply Standard Extract of Centella asiatica ECa 233 and placebo on each side of the cheek after Erbium&#45
YAG laser 4 times/day for 7 days then twice daily for 12 weeks
Experimental Drug,Experimental Drug
Standard Extract of Centella asiatica ECa 233,Placebo

Sponsors

Division of Dermatology, Department of Medicine, Faculty of Medicine, King Chulalongkorn M
Lead Sponsor
Research Affair&#44
Collaborator
Faculty of Medicine&#44
Collaborator
Chulalongkorn university
Collaborator

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patient age 20-60 years old with acne scars

Exclusion criteria

Exclusion criteria: Active acnes Pregnant women or breast- feeding Patient who have photosensitive disease or on photosensitive drug Patient who have dermatological disease ex.psoriasis, cutanous skin cancer

Design outcomes

Primary

MeasureTime frame
Wound healing 12 weeks Antera

Secondary

MeasureTime frame
Post inflammatory hyperpigmentation 12 weeks Antera

Countries

Thailand

Contacts

Public ContactWilawan Damkerngsuntorn

Faculty of Medicine, Chulalongkorn university

wan_damk@hotmail.com085-930-3200

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026